206 related articles for article (PubMed ID: 21055615)
21. (90)Y and (177)Lu labeling of a DOTA-conjugated vitronectin receptor antagonist useful for tumor therapy.
Liu S; Cheung E; Ziegler MC; Rajopadhye M; Edwards DS
Bioconjug Chem; 2001; 12(4):559-68. PubMed ID: 11459461
[TBL] [Abstract][Full Text] [Related]
22. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
[TBL] [Abstract][Full Text] [Related]
23. Ga-68-labeled neolactosylated human serum albumin (LSA) for PET imaging of hepatic asialoglycoprotein receptor.
Choi J; Jeong JM; Yoo BC; Hong MK; Kim YJ; Lee YS; Lee DS; Chung JK
Nucl Med Biol; 2015 Jan; 42(1):53-8. PubMed ID: 25240913
[TBL] [Abstract][Full Text] [Related]
24. Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution method.
Mueller D; Breeman WA; Klette I; Gottschaldt M; Odparlik A; Baehre M; Tworowska I; Schultz MK
Nat Protoc; 2016 Jun; 11(6):1057-66. PubMed ID: 27172166
[TBL] [Abstract][Full Text] [Related]
25. Influence of biological assay conditions on stability assessment of radiometal-labelled peptides exemplified using a 177Lu-DOTA-minigastrin derivative.
Ocak M; Helbok A; von Guggenberg E; Ozsoy Y; Kabasakal L; Kremser L; Decristoforo C
Nucl Med Biol; 2011 Feb; 38(2):171-9. PubMed ID: 21315272
[TBL] [Abstract][Full Text] [Related]
26. A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting.
Meckel M; Kubíček V; Hermann P; Miederer M; Rösch F
Nucl Med Biol; 2016 Nov; 43(11):670-678. PubMed ID: 27560354
[TBL] [Abstract][Full Text] [Related]
27. Simple and convenient radiolabeling of proteins using a prelabeling-approach with thiol-DOTA.
Wängler C; Schirrmacher R; Bartenstein P; Wängler B
Bioorg Med Chem Lett; 2009 Apr; 19(7):1926-9. PubMed ID: 19269174
[TBL] [Abstract][Full Text] [Related]
28. Preparation and preliminary studies on 177Lu-labeled hydroxyapatite particles for possible use in the therapy of liver cancer.
Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
Nucl Med Biol; 2008 Jul; 35(5):589-97. PubMed ID: 18589303
[TBL] [Abstract][Full Text] [Related]
29. Preparation and biological evaluation of 111In-, 177Lu- and 90Y-labeled DOTA analogues conjugated to B72.3.
Mohsin H; Fitzsimmons J; Shelton T; Hoffman TJ; Cutler CS; Lewis MR; Athey PS; Gulyas G; Kiefer GE; Frank RK; Simon J; Lever SZ; Jurisson SS
Nucl Med Biol; 2007 Jul; 34(5):493-502. PubMed ID: 17591549
[TBL] [Abstract][Full Text] [Related]
30. Labeling of tin-soaked albumin microspheres with 68Ga.
Hnatowich DJ
J Nucl Med; 1976 Jan; 17(1):57-60. PubMed ID: 1244450
[TBL] [Abstract][Full Text] [Related]
31. Labelling of
Iori M; Capponi PC; Rubagotti S; Esposizione LR; Seemann J; Pitzschler R; Dreger T; Formisano D; Grassi E; Fioroni F; Versari A; Asti M
Contrast Media Mol Imaging; 2017; 2017():8160134. PubMed ID: 29097938
[TBL] [Abstract][Full Text] [Related]
32. Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.
Helbok A; Decristoforo C; Dobrozemsky G; Rangger C; Diederen E; Stark B; Prassl R; von Guggenberg E
J Liposome Res; 2010 Sep; 20(3):219-27. PubMed ID: 19863193
[TBL] [Abstract][Full Text] [Related]
33. Preparation of [
Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
Nucl Med Biol; 2019; 78-79():31-40. PubMed ID: 31731177
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a radiolabeled small molecule targeting leukocyte function-associated antigen-1 expression in lymphoma and leukemia.
Poria RB; Norenberg JP; Anderson TL; Erion J; Wagner CR; Arterburn JB; Larson RS
Cancer Biother Radiopharm; 2006 Oct; 21(5):418-26. PubMed ID: 17105416
[TBL] [Abstract][Full Text] [Related]
35. Regressive DOTA labelling performance with indium-111 and yttrium-90 over a week of use.
Hainsworth JE; Mather SJ
Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1348. PubMed ID: 16142470
[No Abstract] [Full Text] [Related]
36. Conjugation of DOTA-like chelating agents to peptides and radiolabeling with trivalent metallic isotopes.
Sosabowski JK; Mather SJ
Nat Protoc; 2006; 1(2):972-6. PubMed ID: 17406332
[TBL] [Abstract][Full Text] [Related]
37. AAZTA
Klasen B; Moon ES; Rösch F
Nucl Med Biol; 2021; 96-97():80-93. PubMed ID: 33839678
[TBL] [Abstract][Full Text] [Related]
38. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
[TBL] [Abstract][Full Text] [Related]
39. Gallium-68 labeling of albumin and albumin microspheres.
Wagner SJ; Welch MJ
J Nucl Med; 1979 May; 20(5):428-33. PubMed ID: 120419
[TBL] [Abstract][Full Text] [Related]
40. Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.
Mueller D; Klette I; Baum RP; Gottschaldt M; Schultz MK; Breeman WA
Bioconjug Chem; 2012 Aug; 23(8):1712-7. PubMed ID: 22755505
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
